Sfoglia per Rivista
Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis
2020 Smith RM, Smith RM, Jones RB, Specks U, Bond S, Nodale M, Aljayyousi R, Andrews J, Bruchfeld A, Camilleri B, Carette S, Cheung CK, Derebail V, Doulton T, Forbess L, Fujimoto S, Furuta S, Gewurz-Singer O, Harper L, Ito-Ihara T, Khalidi N, Klocke R, Koening C, Komagata Y, Langford C, Lanyon P, Luqmani RA, Makino H, McAlear C, Monach P, Moreland LW, Mynard K, Nachman P, Pagnoux C, Pearce F, Peh CA, Pusey C, Ranganathan D, Rhee RL, Spiera R, Sreih AG, Tesar V, Walters G, Weisman MH, Wroe C, Merkel P, Jayne D; RITAZAREM, Y Arimura, M Clarkson, J de Zoysa, T Endo, Y Hamano, H Kono, S Lawman, E Muso, K Sada, R Smith, K Suzuki, T Tsukamoto, S Uchida, A Vaglio, R Watts
Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study
2022 Bettiol, Alessandra; Urban, Maria Letizia; Bello, Federica; Fiori, Davide; Mattioli, Irene; Lopalco, Giuseppe; Iannone, Florenzo; Egan, Allyson; Dagna, Lorenzo; Caminati, Marco; Negrini, Simone; Bargagli, Elena; Folci, Marco; Franceschini, Franco; Padoan, Roberto; Flossmann, Oliver; Solans, Roser; Schroeder, Jan; André, Marc; Moi, Laura; Parronchi, Paola; Roccatello, Dario; Sciascia, Savino; Jayne, David; Prisco, Domenico; Vaglio, Augusto; Emmi, Giacomo; Silvestri, Elena; Mattioli, Irene
Targeting the interleukin-5 pathway in EGPA: evidence, uncertainties and opportunities
2022 Berti, Alvise; Atzeni, Fabiola; Dagna, Lorenzo; Del Giacco, Stefano; Emmi, Giacomo; Salvarani, Carlo; Vaglio, Augusto
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis | 2020 | Smith RM, Smith RM, Jones RB, Specks U, Bond S, Nodale M, Aljayyousi R, Andrews J, Bruchfeld A, Camilleri B, Carette S, Cheung CK, Derebail V, Doulton T, Forbess L, Fujimoto S, Furuta S, Gewurz-Singer O, Harper L, Ito-Ihara T, Khalidi N, Klocke R, Koening C, Komagata Y, Langford C, Lanyon P, Luqmani RA, Makino H, McAlear C, Monach P, Moreland LW, Mynard K, Nachman P, Pagnoux C, Pearce F, Peh CA, Pusey C, Ranganathan D, Rhee RL, Spiera R, Sreih AG, Tesar V, Walters G, Weisman MH, Wroe C, Merkel P, Jayne D; RITAZAREM, Y Arimura, M Clarkson, J de Zoysa, T Endo, Y Hamano, H Kono, S Lawman, E Muso, K Sada, R Smith, K Suzuki, T Tsukamoto, S Uchida, A Vaglio, R Watts | |
Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study | 2022 | Bettiol, Alessandra; Urban, Maria Letizia; Bello, Federica; Fiori, Davide; Mattioli, Irene; Lopalco, Giuseppe; Iannone, Florenzo; Egan, Allyson; Dagna, Lorenzo; Caminati, Marco; Negrini, Simone; Bargagli, Elena; Folci, Marco; Franceschini, Franco; Padoan, Roberto; Flossmann, Oliver; Solans, Roser; Schroeder, Jan; André, Marc; Moi, Laura; Parronchi, Paola; Roccatello, Dario; Sciascia, Savino; Jayne, David; Prisco, Domenico; Vaglio, Augusto; Emmi, Giacomo; Silvestri, Elena; Mattioli, Irene | |
Targeting the interleukin-5 pathway in EGPA: evidence, uncertainties and opportunities | 2022 | Berti, Alvise; Atzeni, Fabiola; Dagna, Lorenzo; Del Giacco, Stefano; Emmi, Giacomo; Salvarani, Carlo; Vaglio, Augusto |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile